Navigation Links

Tag: "novartis" at medical news

Novartis files application with FDA for Zometa

Novartis Pharmaceuticals has submitted an application to the Food and Drug Administration, seeking marketing authorization for Zometa in the treatment of bone complications associated with a broad range of tumor types. These include prostate and lung cancer, for which no bisphosphonate therapy is currently approved. The spread of cancerous cells from the original tumor to the bone, can lead to se...

Zometa [Novartis Drug] For Treatment Of Paget’s Diseas

Results of the clinical study carried out by Professor Ian Reed and his team from the University of Auckland in New Zealand has found that the drug Zometa manufactured by Novartis treats Paget’s disease// far better than the drug Actonel produced by Procter and Gamble. ....Paget's disease is a condition in which the bones breaks or becomes weak faster than the normal and the new bone replacement...

Canine Painkiller unveiled by Novartis

Novartis received approval from the Food and Drug Administration to begin marketing Deramaxx, a canine painkiller, which will be used to relieve post-operative pain in dogs. This drug being produced by a Novartis facility at Puerto Rico //is the result of a development project undertaken by Novartis Animal Health that was run for several years at veterinary clinics, colleges and its manufacturing...

Glivec the hot cancer drug from Novartis

Novartis is the world's sixth-largest drugmaker (by sales). ..Novartis was formed after merger of two Swiss companies, Sandoz Ltd. and Ciba-Geigy."Novartis ..is emerging as one of the premier powerhouses in the global pharmaceuticals industry," ..says Richard R. Stover, senior analyst with brokerage Natexis Bleichroeder Inc. ..in New York. The new cancer drug, Glivec's success led to Novartis re...

Novartis MS Drug Shows Promising Results

Data from the extension of a Phase II study to 12 months confirm the significant effects of FTY720, a novel oral medication//, for the treatment of patients with relapsing multiple sclerosis (MS). ....The data, presented at the ECTRIMS/ACTRIMS meeting in Thessalonica, Greece, showed that both patient groups taking FTY720 (1.25 mg and 5 mg) who had experienced a reduction in their annualized rela...

Bird-flu Vaccine Adjuvant Contract Goes to Novartis

Swiss-based global pharmaceutical giant Novartis bagged the contract to make a chemical that would boost the effectiveness of bird-flu vaccines. The $54.8 million contract// was finalised on Wednesday. ....The company already has more than $300 million in federal contracts to fight a possible bird-flu outbreak in humans. ....Two other firms were also awarded contracts on Wednesday by the U.S. D...

Drop Patent Petition, Activists Ask Novartis

Seeking to keep the price of a cancer drug affordable for masses, activists from several countries Monday gathered here and asked Swiss pharmaceutical major Novartis// to withdraw its case against the Indian government that has not granted patent to its anti-cancer medicine. ...."India produces affordable medicines that help millions of people both here and in many other developing countries. A...

E.U. Panel Backs Novartis' Mock-up Pandemic Flu Vaccine

Europe's main medical regulator said it has adopted a positive opinion recommending the granting of a marketing authorization for Focetria, from Novartis //AG (NVS) Vaccines and Diagnostics unit. ....Focetria is a mock-up pandemic influenza vaccine, intended for the prevention of influenza during an officially declared pandemic situation, once the pandemic viral strain has been included. It is...

Indian Court Refers Novartis Plea for Patent on Anti-cancer Drug to a Separate Board

The Madras High Court in the southern Indian state of Tamil Nadu has decided to transfer the Novartis AG’s appeal against the rejection of its patent// plea for the anti-cancer drug Glivec to the Intellectual Property Appellate Board. ....The decision could be considered a temporary setback to the pharma multinational. ..For it cannot hope for any early decision on the patent plea. The Appellat...

Novartis Gleevec Found Effective in Treating Gastro-intestinal Tumors

The US-based National Cancer Institute (NCI) has commended Novartis' anti-cancer tablet, Gleevec, as an// effective therapy for patients suffering from GISTs, metastatic gastro-intestinal tumors. ....These tumours do have a rather complicated name. They are found in the digestive system - the gastrointestinal tract. They develop from cells of connective tissues that control the movements of th...

Novartis Drug Diovan Shows Superior Benefits

Results of a Japanese study have given drug giant Novartis AG, more reasons to smile. According to the study published in The Lancet, the company’s blood pressure// drug Diovan was observed to reduce the risks of strokes and cardiovascular events by up to 40 percent. .. The study titled the Jikei Heart Study, was based on 3,000 people aged 20 to 79, with high blood pressure, ischemic heart dise...

US Court Allows Teva to Deliver Disputed Drug: Novartis

A US court has authorised Israeli generic medicines group Teva to resume deliveries of a blood pressure drug despite a patent lawsuit by Novartis, the Swiss pharmaceutical group said on Tuesday . A US federal court judge in New Jersey rejected on Monday a request from Novartis to stop Teva Pharmaceuticals from resuming shipments of generic versions of the drug, pending a trial in the case, the Sw...
Other Tags
(Date:5/6/2015)... 06, 2015 Dr. Vito C. Quatela, one ... , recently completed a medical mission trip to Hanoi, Vietnam ... those affected by microtia and other deformities of the face. ... and ended on April 26, Dr. Quatela and his team ... a congenital deformity where the outside of the ear is ...
(Date:5/6/2015)... May 06, 2015 The Florida Council ... Health Coalition, Group Victory, Miami Area Geriatric Education Center, ... of Broward County Commission on Substance Abuse, will hold ... May 12-14, at the Riverside Hotel. , This important ... education for everyone as well as clinical training for ...
(Date:5/6/2015)... New york, NY (PRWEB) May 06, 2015 ... on strategy, design, creative and technology, announced today that ... an expert advisor by Shocase, a marketing professional network ... the marketing sector. , Widely regarded as a specialist ... of the most high-profile branding programs over the last ...
(Date:5/6/2015)... In celebration of their twentieth anniversary, Premierlacewigs.com ... will give away a deluxe human hair lace wig valued ... to enter on a third-party giveaway tool. The important thing ... be the winner. , The hair is a crown, a ... for such a jewel for the past 20 years. Whether ...
(Date:5/6/2015)... Boston, MA (PRWEB) May 06, 2015 Most ... years of long-term nursing or other care after age 65. ... beyond are saving for it or even talking about it, ... By not planning, people risk two problems. One is losing ... off to their families," says Dr. David Grabowski, a professor ...
Breaking Medicine News(10 mins):Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 2Health News:Dr. Vito Quatela Completes Successful 10-Day Medical Mission Trip to Hanoi, Vietnam 3Health News:Conference on Problem Gambling to be held in Ft. Lauderdale, FL 2Health News:Shocase Selects MBLM’s Claude Salzberger as Company Advisor 2Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Start Planning Now for Long-Term Care, from the May 2015 Harvard Health Letter 2
(Date:4/14/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... York Design Awards under the category  ,Product Design – ... Awards are part of a global multi-disciplinary awards program. ... the marketplace, industry and judging panel. Winners will be ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... 23, 2015, after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
(Date:4/2/2015)... At its 2015 ACMG Annual Clinical Genetics ... the American College of Medical Genetics and Genomics (ACMG) ... Board.  Members of the ACMG Board of Directors serve ... advancing its policies and programs. ACMG is the national ... an eventful time in medical genetics and genomics.  We ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
Other Contents